Literature DB >> 15298668

Melatonin stimulates calmodulin phosphorylation by protein kinase C.

Elena Soto-Vega1, Isaura Meza, Gerardo Ramírez-Rodríguez, Gloria Benitez-King.   

Abstract

Calmodulin (CaM)-dependent processes can be modulated by the availability of Ca(+2), the subcellular distribution of both CaM and its target proteins, CaM antagonism, and post-translational modifications such as CaM phosphorylation. Melatonin, the pineal secretory product synthesized during the dark phase of the photoperiod is an endogenous CaM antagonist. This indolamine causes CaM subcellular redistribution in epithelial MDCK and MCF-7 cells, and selectively activates protein kinase C alpha (PKC alpha) in neuronal N1E-115 cells. In the present work we have characterized the phosphorylation of CaM mediated by PKC alpha and its stimulation by melatonin in an in vitro reconstituted enzyme system. Additionally, the participation of MAPK and ERKs, downstream kinases of the PKC signaling pathway, was explored utilizing MDCK cell extracts as source of these kinases. Phosphorylation of CaM was characterized in the whole cells by MDCK cell metabolic labeling with [(32)P]-orthoposhospate, and CaM separation by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, as well as by immunocolocalization of phosphorylated threonine/serine residues and CaM in cultured cells incubated with melatonin. Our results show that melatonin increased CaM phosphorylation by PKC alpha with an EC(50) of 10(-8) m in the presence of the phorbol ester, phorbol-12-myristate-13-acetate (PMA) in the in vitro reconstituted enzyme system. An increase in phosphorylated CaM was also observed in cells cultured with melatonin, or PMA for 2 hr, while, PKC, MAPK, or ERK inhibitors abolished CaM phosphorylation elicited by melatonin in MDCK cell extracts. Our data show that melatonin can stimulate phosphorylation of CaM by PKC alpha in the in vitro reconstituted system and suggest that in MDCK cells this phosphorylation is accomplished by PKC. Modification of CaM by melatonin can be another route to inhibit CaM interaction with its target enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298668     DOI: 10.1111/j.1600-079X.2004.00141.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  17 in total

Review 1.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

2.  Photoperiod-mediated impairment of long-term potention and learning and memory in male white-footed mice.

Authors:  J C Walton; Z Chen; Z M Weil; L M Pyter; J B Travers; R J Nelson
Journal:  Neuroscience       Date:  2010-12-08       Impact factor: 3.590

Review 3.  Melatonin as a central molecule connecting neural development and calcium signaling.

Authors:  Joice de Faria Poloni; Bruno César Feltes; Diego Bonatto
Journal:  Funct Integr Genomics       Date:  2011-04-05       Impact factor: 3.410

Review 4.  Revisiting the role of melatonin in human melanocyte physiology: A skin context perspective.

Authors:  Alec Sevilla; Jérémy Chéret; Radomir M Slominski; Andrzej T Slominski; Ralf Paus
Journal:  J Pineal Res       Date:  2022-04       Impact factor: 13.007

Review 5.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

6.  Melatonin down-regulates volume-sensitive chloride channels in fibroblasts.

Authors:  Ismail Ben Soussia; Frédérique Mies; Robert Naeije; Vadim Shlyonsky
Journal:  Pflugers Arch       Date:  2012-07-27       Impact factor: 3.657

7.  The effect of calmodulin antagonists on scoliosis: bipedal C57BL/6 mice model.

Authors:  Ibrahim Akel; Gokhan Demirkiran; Ahmet Alanay; Sevilay Karahan; Ralph Marcucio; Emre Acaroglu
Journal:  Eur Spine J       Date:  2009-02-26       Impact factor: 3.134

8.  Scientific basis for the potential use of melatonin in bone diseases: osteoporosis and adolescent idiopathic scoliosis.

Authors:  E J Sánchez-Barceló; M D Mediavilla; D X Tan; R J Reiter
Journal:  J Osteoporos       Date:  2010-06-01

Review 9.  Circadian disruption and breast cancer: an epigenetic link?

Authors:  David Z Kochan; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-07-10

10.  Melatonin anticancer effects: review.

Authors:  Giuseppe Di Bella; Fabrizio Mascia; Luciano Gualano; Luigi Di Bella
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.